Wells Fargo & Company »

Lyra Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3k 247 5.24
2023-09-30 $863 221 3.91
2023-06-30 $488 119 4.11
2022-12-31 $355 113 3.14
2022-09-30 $999 110 9.09
2022-06-30 $999 111 9.01
2022-03-31 $0 537 0.00
2021-12-31 $0 537 0.00
2021-09-30 $0 537 0.00
2021-06-30 $4.2k 523 8.00
2021-03-31 $24k 2.1k 11.51
2020-12-31 $40k 3.5k 11.36
2020-09-30 $12k 1.1k 11.08
2020-06-30 $24k 2.1k 11.52